Initial Therapy of CML with Dose-Optimized Imatinib: A Single Institution Experience

We report here the efficacy and tolerability of dose-adjusted imatinib in an academic setting.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research